Results: On univariate analysis, Proton Pump Inhibitors (PPIs) were associated with a higher risk of CE (OR = 2.14; 95 % CI: 1.30 to 3.54); steroid use also increased the risk of CE (OR = 3.55; 95 % CI: 2.10 to 6.00). Furthermore, concurrent use of PPIs & steroids substantially raised this risk (OR = 13.8; 95 % CI 5.07 to 37.5), suggesting a synergistic eff ect. When adjusted for covariates (cancer, chemotherapy/radiation, antibiotic use, hypothyroidism, anemia, chronic liver disease & diabetes), anemia was found to decrease the odds ratio for PPI to 1.67 (95 % CI 1.02 to 2.75) and for steroids to 1.69 (95 % CI to 1.03 to 2.87). Hypothyroidism also substantially reduced the observed risk associated with steroid use. However, neither anemia nor hypothyroidism reduced the odds ratio for combined use of steroids and PPI. Conclusion: Our data suggest that patients who have been treated with steroids or PPIs are at an increased risk for developing CE. Th is study also suggests that steroids and PPI act synergistically to greatly increase the likelihood of developing CE.
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Th e Role of Antirefl ux Stent for Distal Esophageal Malignancy
Tarek Sawas, MD 1 , Won Cho, MD 2 . 1. Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI; 2. MedStar Washington Hospital Center, Washington, DC. Introduction: Incurable distal esophageal malignancy is a challenging medical condition usually requires palliative treatment with endoscopic stenting to alleviate dysphagia and provide comfort for patients. Th e use of conventional self expandable metal stent is associated with increased risk for acid refl ux causing esophagitis, aspiration and pneumonia. Stents with antirefl ux mechanism have been developed to overcome this problem. We aim to perform a systematic review and meta-analysis of randomized controlled trials (RCT) comparing antirefl ux stent to the conventional stent for inoperable distal esophageal malignancy. Methods: We searched Pubmed and Embase for RCTs that compared antirefl ux stent to conventional stent. Two reviewers selected the studies. Quality for each included study was assessed by consort system. No study was eliminated based on the quality. Heterogeneity was analyzed by Cochran's Q statistics. Mantel Haenszel odds ratio (OR) and mean diff erences (MD) were calculated with random eff ects mode. RevMan 5.2 from Cochrane was used for analysis. Results: 7 RCTs involving 282 patients (133 ARS, 149 CS) were included. Insertion success rate was similar in both groups (OR: 0.46, 95% confi dent interval CI: 0.04, 5.75). Both stents improved dysphagia without statistically signifi cant diff erence in dysphagia score between the two methods (Mean diff erence MD 0.23, 95% CI: -0.06, 0.53). Th e incidence of post stenting refl ux was not statistically signifi cant between ARS and CS (OR: 0.28, 95% CI: 0.01, 9.79). the two stents were also similar in terms of stent migration (OR: 1.28, 95% CI: 0.53, 3.08) and mortality (OR: 1.52, 95% CI: 0.49, 4.72). Conclusion: Although antirefl ux stent is an eff ective method to relief dysphagia in distal esophageal malignancy, it has failed to show superiority over the conventional stent in preventing gastroesophageal refl ux.
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Eosinophilic Esophagitis Is Rare in Hispanic Patients: Results of a Population Based Study
Christine Yu, MD 1 , Ihsan Al-Bayati, MD 2 , Marco A. MD 2 , Sharareh Moraveji, MD 2 , Richard McCallum, MD, FACG 2 . 1. Texas Tech University Health Sciences Center, El Paso , TX; 2. Texas Tech University Health Sciences Center, El Paso, TX. Introduction: No large population based study has addressed the prevalence of Eosinophilic Esophagitis (EoE) in the Hispanic population. A few studies have identifi ed a lower incidence of EoE in the Hispanic population but were mainly pediatric or focused on other minorities. Since the majority of the population of El Paso, Texas is of Hispanic descent, we conducted a study with the goal to determine the prevalence of EoE in the Hispanic and Caucasian ethnicities. Methods: Retrospective examination on all patients who underwent an upper endoscopy for any clinical indication with accompanying esophageal biopsies, from 12/7/2007 to 3/2/2015, was conducted. Data was collected from both our endoscopic and hospital electronic medical record systems to obtain ethnicity (Hispanic, white, and non-white/ non-Hispanic) pertinent demographic information, endoscopic fi ndings, and pathology reports. Th e total number of upper endoscopies performed in that time period was reviewed in order to determine how many esophageal biopsies met the pathology criteria for EoE. Th e demographic information from these patients with biopsy-proven EoE was then compared according to their diff erent ethnicities. Results: In the approximately 7 year period, a total of 1700 patients underwent upper endoscopies with esophageal biopsies. Of these, 1350 (80%) were of Hispanic descent and 350 (20%) were from non-Hispanic patients. From the 350 non-Hispanic patients, 179 (51%) were identifi ed as white or Caucasian; therefore 10.5% of our total population was of Caucasian descent. A total of 32 esophageal biopsies met pathology criteria for the diagnosis of EoE -prevalence 1.9%. Th ese patients ranged in age from 2 to 67 (56% between 21-50 years of age) and 53% were male. Of the positive EoE biopsies, 16 (50%) were of Hispanic ethnicity -overall prevalence of 1.2%; 13 (40.6%) were of white or Caucasian descentprevalence of 7.3% (See Table) . Conclusion: Based on our data from an 80% Hispanic patient base in El Paso, Texas, undergoing esophageal biopsies, the prevalence of EoE in the Hispanic population is rare (1.2%), while its prevalence in Caucasians is 6-fold higher (7.3%). In view of these fi ndings, further research should focus on genetic markers of EoE in esophageal biopsies from patients of Hispanic descent.
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Same-Day Discharge Aft er Flexible Endoscopic Incisional Th erapy (FEIT) for Zenker's Diverticulum
David L. Diehl, MD 1 , Harshit S. Khara, MD 2 , Kimberly Fairley, DO 2 . 1. Division of Gastroenterology and Hepatology, Geisinger Medical Center, Danville, PA; 2. Geisinger Medical Center, Danville, PA. Introduction: Flexible endoscopic incisional therapy (FEIT) has become an accepted alternative to surgery for management of Zenker's diverticulum (ZD). Historically, operative management consisted of open diverticulectomy with or without cricopharyngeal myotomy with a rigid operative speculum. In multiple case series, FEIT has been shown to have a high initial and long-term success rate and excellent safety profi le. It can be off ered as primary therapy for ZD, or can be used for cases in which the surgical approach has failed. Procedure times of less than an hour are comparable to surgery. Th e potential to complete this procedure on an outpatient basis with same day discharge would represent an advantage over surgical approaches. Methods: Our advanced procedure database was searched for all FEIT procedures done for ZD. Th e medical chart was reviewed for procedural details and outcomes of these procedures. 11 FEIT procedures were done in 9 outpatients with ZD who were discharged the same day aft er the procedure. Results: Th e mean age of the patients was 77.4 years (range 54-90). One patient had FEIT on 3 occasions for a technically diffi cult and narrow ZD; the others could be treated in a single session. Dysphagia was the main presenting symptoms in all, 5 patients also had signifi cant weight loss, and 3 had recurrent aspiration episodes. 4 patients had previous therapy (3 surgical and 1 FEIT). All 11 procedures were done without complication. Only one case of minor intraprocedural bleeding was encountered, and was readily controlled with a Coagrasper. 7/8 patients (88%) had complete relief aft er a single FEIT session. Procedure times averaged 41 min (range 14-73). Th e Hook Knife was used in 5 cases early in the series; for the last 6, use of the IT2 knife was adopted, which tended to shorten procedure times. Conclusion: Incisional therapy of ZD with a needle knife instrument is safe, effi cient and eff ective. In the absence of immediate complication, it is reasonable to discharge the patients on the same day as FEIT. Th e ability to treat certain patients not amenable to surgical management, comparable eff ectiveness, and decreased costs due to the ability to avoid post-procedure hospitalization may make FEIT the favored initial therapy for ZD.
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